Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures

Journal of Virology

Volumn 73, Issue 12, 1999, Pages 10208-10213

  Noah, Diana L ^a   Blum, Mary Ann ^a   Sherry, Barbara ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; TRANSCRIPTION FACTOR;

ARTICLE; GENETIC TRANSFECTION; MOUSE; MUSCLE FIBER CULTURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REOVIRUS; VIRUS INFECTION; VIRUS MYOCARDITIS;

EID: 0032710385     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.12.10208-10213.1999     Document Type: Article

References (51)

1. Au, W. C., P. A. Moore, W. Lowther, Y. T. Juang, and P. M. Pitha. 1995. Identification of a member of the Interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92:11657-11661.
2. Baty, C. J., and B. Sherry. 1993. Cytopathogenic effect in cardiac myocytes but not in cardiac fibroblasts is correlated with reovirus-induced acute myocarditis. J. Virol. 67:6295-6298.
3. Bowles, N. E., P. J. Richardson, E. G. J. Olsen, and L. C. Archard. 1986. Detection of coxsackie B virus-specific RNA sequences in myocardial biopsies from cases of myocarditis and dilated cardiomyopathy. Lancet i:1120-1122.
4. Cherry, J. D. 1995. Enteroviruses, p. 404-446. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infant, 4th ed. W. B. Saunders, Philadelphia, Pa.
5. Chow, L. H., K. W. Beisel, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Investig. 66:24-31.
6. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
7. Daly, C., and N. C. Reich. 1995. Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon alpha/beta-stimulated genes. J. Biol. Chem. 270:23739-23746.
8. De Castro, S., G. D'Amati, P. Gallo, D. Cartoni, P. Santopadre, V. Vullo, A. Cirelli, and G. Migliau. 1994. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. J. Am. Coll. Cardiol. 24:1018-1024.
9. Dirks, W., S. Mittnacht, M. Rentrop, and H. Hauser. 1989. Isolation and functional characterization of the murine interferon-beta 1 promoter. J. Interferon Res. 9:125-133.
10. Fujita, T., Y. Kimura, M. Miyamoto, E. L. Barsoumian, and T. Taniguchi. 1989. Induction of the endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337:270-272.
11. Fujita, T., J. Sakakibura, Y. Sudo, M. Miyamoto, Y. Kimura, and T. Taniguchi. 1988. Evidence for a nuclear factor(s), IRF-1 mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J. 7:3397-3405.
12. Harada, H., T. Fujita, M. Miyamoto, V. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
13. Heim, A., M. Stille-Siegner, R. Kandolf, H. Kreuzer, and H. R. Figulla. 1994. Enterovirus-induced myocarditis: hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-alpha. Clin. Cardiol. 17:563-565.
14. Herzum, M., V. Ruppert, B. Kuytz. H. Jomaa, I. Nakamura, and B. Maisch. 1994. Coxackievirus B3 infection leads to cell death of cardiac myocytes. J. Mol. Cell. Cardiol. 26:907-913.
15. Hottinger, M. O., and G. J. Nabel. 1998. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 72:8252-8256.
16. Juang, Y.-T., W. Lowther, M. Kellum, W.-C. Au, R. Lin, J. Hiscott, and P. M. Ptha. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95: 9837-9842.
17. Kandolph, R., K. Klingel, H. Mertsching, A. Canu, C. Hohenadl, R. Zell, Y. Reimann, A. Heim, B. M. McManus, A. K. Foulis, H.-P. Schultheiss, E. Erdmann, and G. Riecker. 1991. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur. Heart J. 12:49-55.
18. Kaplan, M. H., S. W. Klein, J. McPhee, and R. G. Harper. 1983. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 5:1019-1032.
19. Leslie, K., R. Blay, C. Halsch, A. Lodge, A. Weller, and S. A. Huber. 1989. Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2:191-203.
20. Lin, R., C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott. 1999. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19:959-966.
21. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteosome-mediated degredation. Mol. Cell. Biol. 19:2986-2996.
22. Lin, R., Y. Mamane, and J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivating and autoinhibitory domains. Mol. Cell. Biol. 19:2465-2474.
23. Lin, R., A. Mustafa, H. Nguyen, D. Gewert, and J. Hiscott. 1994. Mutational analysis of the interferon regulatory factors 1 and 2. J. Biol. Chem. 269: 17542-17549.
24. Marboe, C. C., and J. J. Fenoglio. 1988. Pathology and natural history of human myocarditis. Pathol. Immunopathol. Res. 7:226-239.
25. Marie, I., J. Durbin, and D. E. Levy. 1998, Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:6660-6669.
26. Martin, A., S. Webber, F. Fricker, R. Jaffe, G. Demmler, D. Kearney, Y.-H. Zhang, J. Bodurtha, B. Gelb, J. Ni, T. Bricker, and J. A. Towbin. 1994. Acute myocarditis: rapid diagnosis by PCR in children. Circulation 99:330-339.
27. Miric, M., A. Miskovic, J. D. Vasiljevic, N. Keserovic, and M. Pesic. 1995. Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy. European Heart J. 16:150-152.
28. Miric, M., J. Vasiljevic, M. Bojic, Z. Popovic, N. Keserovic, and M. Pesic. 1996. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones. Initial results. Heart 75:596-601.
29. Miyamoto, M., T. Fujita, Y. Kimura, M. Maruyama, H. Harada, Y. Sudo, T. Miyata, and T. Taniguchi. 1988. Regulated expression of a gene encoding a nuclear factor, IRF-1, that binds specifically to IFN-beta gene regulatory elements. Cell 54:903-913.
30. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
31. Morimoto, S.-I., K. Yamada, N. Kubo, Y. Mizuno, M. Hasumi, S. Hiramitsu, A. Uemura, K. Kimura, T. Nishikawa, and M. Sekiguchi. 1992. Clinical and pathological features of chronic myocarditis: four autopsy cases presenting as dilated cardiomyopathy in life. Am. J. Cardiovasc. Pathol. 4:181-191.
32. Navarro, L., K. Mowen, S. Rodems, B. Weaver, N. Reich, D. Spector, and M. David. 1998. Cytomeglalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:3796-3802.
33. Noah, D. L., M. A. Blum, and B. Sherry. 1998. Transfection of primary cardiac myocyte cultures with DNA and anti-sense oligonucleotides using FuGene6 transfection reagent. Biochemica 2:38-40.
34. Reis, L. F., H. Harada, J. D. Wolchok, T. Taniguchi, and J. Vilcek. 1992. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBO J. 11:185-193.
35. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072.
36. Rose, N. R., and S. L. Hill. 1996. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 80:S92-S99.
37. Sato, M., N. Tanaka, M. Hata, E. Oda, and T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene. FEBS Lett. 452:112-116.
38. Schafer, S. L., R. Lin, P. A. Moore, J. Hiscott, and P. M. Pitha. 1998. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273:2714-2720.
39. See, D. M., and J. G. Tilles. 1991. Viral myocarditis. Rev. Infect. Dis. 13:951-956.
40. Sherry, B., C. J. Baty, and M. A. Blum. 1996. Reovirus-induced acute myocarditis in mice correlates with viral RNA synthesis rather than generation of infectious virus in cardiac myocytes. J. Virol. 70:6709-6715.
41. Sherry, B., and M. A. Blum. 1994. Multiple viral core proteins are determinants of reovirus-induced acute myocarditis. J. Virol. 68:8461-8465.
42. Sherry, B., X. Li, K. L. Tyler, J. M. Cullen, and H. W. Virgin. 1993. Lymphocytes protect against and are not required for reovirus-induced myocarditis. J. Virol. 67:6119-6124.
43. Sherry, B., F. J. Schoen, E. Wenske, and B. N. Fields. 1989. Derivation and characterization of an efficiently myocarditic reovirus variant. J. Virol. 63: 4840-4849.
44. Sherry, B., J. Torres, and M. A. Blum. 1998. Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditic and are determined by viral core proteins. J. Virol. 72:1314-1323.
45. Stille-Sieggener, M., A. Heim, and H. R. Figulla. 1995. Subclassification of dilated cardiomyopathy and interferon treatment. Eur. Heart J. 16:147-149.
46. Tracy, S., V. Wiegand, B. McManus, C. Gauntt, M. Pallansch, M. Beck, and N. Chapman. 1990. Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J. Am. Coll. Cardiol. 15:1688-1694.
47. Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines, p. 375-400. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
48. Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1359-1368.
49. Wenger, N. K., W. H. Abelmann, and W. C. Roberts. 1990. Myocarditis, p. 1256-1277. In J. W. Hurst and R. C. Schlant (ed.), The heart, arteries, and veins. McGraw-Hill Book Co., New York, N. Y.
50. Woodruff, J. F. 1980. Viral myocarditis: a review. Am. J. Pathol. 101:427-479.
51. Yoneyama, M., W. Suhara, Y. Fukuhara, M. Fukuda, E. Nishida, and T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor containing complex containing IRF-3 and CBP/p300. EMBO J. 17:1087-1095.